Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-017842-30Phase 2Completed
Phase 2, randomised, double-blind trial in delirium comparing Intravenous haloperidol with Placebo (2 arms). Primary endpoint: Delirium/coma-free days at 14 days. Started Jul 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-017842-30.